Medications

Outpatient anticoagulant therapy may cut COVID-19 admission risk

(HealthDay)—Individuals using anticoagulation therapy on an outpatient basis who are diagnosed with COVID-19 have a reduced risk for hospital admission, according to a study published online Sept. 24 in EClinicalMedicine.

Medications

Apixaban not superior to standard care after TAVR

The blood thinner apixaban was not superior to standard of care following transcatheter aortic valve replacement (TAVR), according to findings from a new trial called ATLANTIS presented at the American College of Cardiology's ...

Neuroscience

Aspirin not as effective as anticoagulation

In a multicenter study led by the University Hospital and the University Geriatric Medicine FELIX PLATTER Basel, a research group with participation from University of Basel, Inselspital, Bern University Hospital, the University ...

page 1 from 19